| Daiichi Sankyo (Schweiz) AG - VANFLYTA 26.5 mg, Filmtabletten | | 69710 | | 02 | | VANFLYTA 26.5 mg | | Filmtabletten | | L01EX11 | | Quizartinib | | 31.03.2025 | | |
| | Composition | | quizartinibi dihydrochloridum 30 mg corresp. quizartinibum 26.5 mg, hydroxypropylbetadexum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, talcum, triacetinum, E 171, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Quizartinibi Dihydrochloridum | 30 mg correspond Quizartinibum 26.5 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Flavum) | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylbetadexum | | | | Hypromellosum | | Überzug | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Talcum | | | | Triacetinum | | |
|
| |
|
